UHS:NYE-Universal Health Services Inc. (USD)

EQUITY | Medical Care Facilities | New York Stock Exchange

Last Closing

USD 187.85

Change

0.00 (0.00)%

Market Cap

USD 11.70B

Volume

0.59M

Analyst Target

USD 129.60
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Universal Health Services Inc through its subsidiaries is engaged in the business of owning and operating acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-15 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

-3.90 (-0.96%)

USD 104.14B
THC Tenet Healthcare Corporation

-1.70 (-1.01%)

USD 16.10B
DVA DaVita HealthCare Partners Inc

-0.01 (-0.01%)

USD 13.76B
EHC Encompass Health Corp

+2.44 (+2.63%)

USD 9.32B
CHE Chemed Corp

+4.27 (+0.72%)

USD 8.66B
CON Concentra Group Holdings Paren..

-0.08 (-0.34%)

USD 2.93B
ARDT Ardent Health Partners, Inc.

+0.28 (+1.47%)

USD 2.59B
NHC National HealthCare Corporatio..

-0.03 (-0.02%)

USD 1.96B
AMN AMN Healthcare Services Inc

-2.34 (-5.27%)

USD 1.69B
AGL agilon health Inc

+0.02 (+0.52%)

USD 1.58B

ETFs Containing UHS

NEWZ StockSnips AI-Powered Sen.. 4.01 % 0.00 %

+0.05 (+0.18%)

N/A
PTH Invesco DWA Healthcare Mo.. 2.78 % 0.60 %

-0.40 (0.18%)

USD 0.15B
FXH First Trust Health Care A.. 2.65 % 0.63 %

-0.50 (0.18%)

USD 1.29B
FHH-F:CA First Trust AlphaDEX U.S... 2.62 % 0.00 %

N/A

CAD 0.01B
XHS SPDR® S&P Health Care Se.. 2.54 % 0.35 %

-0.39 (0.18%)

USD 0.08B
XLVE:CA Mulvihill U.S. Health Car.. 1.94 % 0.00 %

-0.04 (0.18%)

N/A
RSPH Invesco S&P 500® Equal.. 1.88 % 0.00 %

-0.07 (0.18%)

USD 1.02B
ZUH:CA BMO Equal Weight US Healt.. 1.77 % 0.39 %

-0.04 (0.18%)

CAD 0.28B
ZHU:CA BMO Equal Weight US Healt.. 1.77 % 0.00 %

N/A

CAD 0.01B
SYLD 1.33 % 0.59 %

N/A

N/A
LSAF LeaderSharesTM AlphaFacto.. 1.17 % 0.75 %

+0.03 (+0.18%)

USD 0.16B
ENG:PA BNP Paribas EASY ECPI Glo.. 1.17 % 0.00 %

+0.09 (+0.18%)

USD 0.22B
XU61:F BNP Paribas Easy SICAV - .. 1.17 % 0.00 %

N/A

USD 0.24B
XU61:XETRA BNP Paribas EASY ECPI Glo.. 1.17 % 0.00 %

+0.07 (+0.18%)

USD 0.27B
ENGUS:PA BNP Paribas Easy ECPI Glo.. 1.17 % 0.00 %

+0.07 (+0.18%)

N/A
AFLG First Trust Active Factor.. 1.12 % 0.00 %

+0.09 (+0.18%)

USD 0.02B
2B77:XETRA iShares Ageing Population.. 0.62 % 0.00 %

+0.01 (+0.18%)

USD 0.50B
2B77:F iShares Ageing Population.. 0.62 % 0.00 %

N/A

N/A
QDVC:XETRA iShares Edge MSCI USA Siz.. 0.38 % 0.00 %

+0.02 (+0.18%)

USD 0.19B
IUSZ:SW iShares Edge MSCI USA Siz.. 0.38 % 0.00 %

N/A

N/A
JPGL:XETRA JPM Global Equity Multi-F.. 0.35 % 0.00 %

+0.08 (+0.18%)

USD 0.22B
JPGL:LSE JPM Global Equity Multi-F.. 0.35 % 0.00 %

+0.12 (+0.18%)

USD 0.18B
JPGL:F JPmorgan ETFs Ireland Ica.. 0.35 % 0.00 %

+0.09 (+0.18%)

USD 0.22B
JPGL:SW JPM Global Equity Multi-F.. 0.35 % 0.00 %

+0.33 (+0.18%)

N/A
FHH:CA First Trust AlphaDEX US H.. 0.00 % 0.77 %

-0.89 (0.18%)

CAD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 23.23% 64% D 93% A
Dividend Return 0.26% 38% F 10% F
Total Return 23.49% 64% D 93% A
Trailing 12 Months  
Capital Gain 26.40% 68% D+ 86% B+
Dividend Return 0.54% 25% F 6% D-
Total Return 26.93% 68% D+ 85% B
Trailing 5 Years  
Capital Gain 52.20% 67% D+ 73% C
Dividend Return 2.75% 29% F 8% B-
Total Return 54.96% 67% D+ 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 7.09% 57% F 64% D
Dividend Return 7.59% 57% F 59% D-
Total Return 0.50% 22% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 27.28% 78% C+ 39% F
Risk Adjusted Return 27.83% 65% D 50% F
Market Capitalization 11.70B 91% A- 86% B+

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 17.30 53% 53%
Price/Book Ratio 1.83 67% 45%
Price / Cash Flow Ratio 9.93 30% 39%
Price/Free Cash Flow Ratio 9.63 48% 44%
Management Effectiveness  
Return on Equity 13.31% 62% 68%
Return on Invested Capital 8.76% 58% 61%
Return on Assets 5.82% 78% 78%
Debt to Equity Ratio 77.83% 55% 45%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.